Litcius/Paper detail

IL-33 antagonism does not improve chronic atopic dermatitis: What can we learn?

Charles F. Schuler, Jóhann E. Guðjónsson

2022Journal of Allergy and Clinical Immunology13 citationsDOIOpen Access PDF

Topics & Concepts

Atopic dermatitisMedicineAsthmaAllergyFilaggrinThymic stromal lymphopoietinDupilumabRandomized controlled trialImmunologyDermatologyInternal medicineDermatology and Skin DiseasesAllergic Rhinitis and SensitizationIL-33, ST2, and ILC Pathways
IL-33 antagonism does not improve chronic atopic dermatitis: What can we learn? | Litcius